Mixed trend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend up since Oct 1 · below the Ichimoku cloud · RSI 61 · MACD above its signal
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $187.6K | 0.00% | 43.43K | −80% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a OM trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 35.0 | -30.3 | 10.0 | 11.2 | 14.5 | -11.7 | 5.8 | -16.4 | -21.5 | 35.3 | +9.4% | ||
| 2025 | -27.9 | -9.0 | 1.3 | -3.8 | 65.1 | 9.3 | -16.4 | -13.4 | 1.5 | -7.1 | -65.2 | -18.6 | −77.7% |
| 2024 | -43.8 | 3.6 | -29.5 | 14.0 | 47.4 | 3.2 | -7.8 | -85.1 | 27.7 | -15.8 | 57.2 | 23.9 | −79.5% |
| 2023 | 8.9 | -18.9 | -19.3 | -2.2 | 15.8 | 5.0 | -5.9 | -33.9 | -20.1 | -67.5 | 48.0 | 3.2 | −79.0% |
| 2022 | -19.3 | 18.2 | 3.3 | -23.2 | -37.5 | -31.8 | 4.0 | 18.4 | -12.9 | -2.4 | 35.6 | 22.5 | −44.0% |
| 2021 | -8.8 | -3.9 | 9.2 | 10.2 | -19.4 | 3.5 | -18.0 | 20.3 | 0.3 | 7.7 | -11.0 | -2.8 | −18.9% |
| 2020 | -7.1 | 37.7 | -11.2 | +13.7% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Leonard Braden MichaelBeneficial Owner of more than 10% of a Class of Security | Purchase at price 3.53 - 3.88 per share. | 244.9K | $870.26K |
| Aug 16, 2026 | Trigg Leslie LChief Executive Officer | Sale at price 4.39 per share. | 3.4K | $15.09K |
| Aug 16, 2026 | Gaeta ReneeChief Financial Officer | Sale at price 4.39 per share. | 4.5K | $19.94K |
| Aug 16, 2026 | Brottem John L.General Counsel | Sale at price 4.39 per share. | 2.6K | $11.55K |
| Jun 25, 2026 | Trigg Leslie LChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 99.2K | — |
| Jun 25, 2026 | Gaeta ReneeChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 71.6K | — |
| Jun 25, 2026 | Brottem John L.General Counsel | Stock Award(Grant) at price 0.00 per share. | 59.8K | — |
| Jun 3, 2026 | Grossman Donald KeithDirector | Stock Award(Grant) at price 0.00 per share. | 10.7K | — |
| Jun 3, 2026 | Hackett Patrick T.Director | Stock Award(Grant) at price 0.00 per share. | 10.7K | — |
| Jun 3, 2026 | Drexler KarenDirector | Stock Award(Grant) at price 0.00 per share. | 10.7K | — |
| Jun 3, 2026 | Lang Brent DDirector | Stock Award(Grant) at price 0.00 per share. | 10.7K | — |
| Jun 3, 2026 | Prange Karen N.Director | Stock Award(Grant) at price 0.00 per share. | 10.7K | — |
| Jun 3, 2026 | O'Boyle Kevin CDirector | Stock Award(Grant) at price 0.00 per share. | 10.7K | — |
| Jun 2, 2026 | Gaeta ReneeChief Financial Officer | Sale at price 4.94 per share. | 17.7K | $87.30K |
| May 14, 2026 | Trigg Leslie LChief Executive Officer | Sale at price 3.70 per share. | 3.4K | $12.75K |
| May 14, 2026 | Brottem John L.General Counsel | Sale at price 3.70 per share. | 2.6K | $9.76K |
| May 14, 2026 | Nash MarcOfficer | Sale at price 3.70 per share. | 1.6K | $5.85K |
| May 14, 2026 | Leonard Braden MichaelBeneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 5.00 per share. | 323K | $1.61M |
| May 10, 2026 | Leonard Braden MichaelBeneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 5.00 per share. | 294.5K | $1.47M |
| Apr 5, 2026 | Elliott Derick AOfficer | Stock Award(Grant) at price 0.00 per share. | 96K | — |
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Buy / hold / sell counts